Vivaldi Capital Management LP cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 8.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,025 shares of the medical research company’s stock after selling 197 shares during the […]
Legacy Advisors LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 26.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,536 shares of the medical research company’s stock after selling 1,673 shares during the […]
Congress Wealth Management LLC DE decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,492 shares of the medical research company’s stock after selling 151 shares during […]
Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) – Equities research analysts at Zacks Research increased their Q4 2024 EPS estimates for shares of Thermo Fisher Scientific in a research note issued on Thursday, May 16th. Zacks Research analyst R. Anand now forecasts that the medical research company will post earnings per share of $5.94 […]
Seven Mile Advisory purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 463 shares of the medical research company’s stock, valued at approximately $246,000. A number of other […]